The effect of prolonged treatment with imipramine on the biosynthesis and functional characteristics of D2 dopamine receptors in the rat caudate putamen

被引:15
作者
Dziedzicka-Wasylewska, M [1 ]
Rogoz, R [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Pharmacol, PL-31343 Krakow, Poland
关键词
imipramine; D-2 dopamine receptor mRNA; H-3]-N-0437; cyclic AMP; rat caudate putamen;
D O I
10.1038/sj.bjp.0701681
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The present study shows the effects of imipramine in a single dose (10 mg kg(-1), p.o.) or following repeated (14 days, twice a day) treatment on the level of mRNA coding for D-2 dopamine receptors in the rat caudate putamen (CP). Repeated administration of imipramine resulted in the increase of the level of mRNA coding for D-2 dopamine receptors. 2 Radioligand binding studies with the D-2 receptor agonist, [H-3]-N-0437, indicated, that following imipramine administration, the affinity of the agonist for the D-2 dopamine receptor significantly increased, though without any alterations in the B-Max. 3 Pharmacological manipulations (by use of forskolin, GppNHp and quinpirole) of the cyclic AMP generating system, ex vivo following administration of imipramine indicated that an up-regulation of factors inhibiting cyclic GMP formation takes place. 4 Most probably it is the D-2 dopamine receptor which undergoes functional up-regulation, resulting from the enhancement of its biosynthesis.
引用
收藏
页码:833 / 838
页数:6
相关论文
共 53 条
[1]   CA2+/CALMODULIN DISTINGUISHES BETWEEN GUANYL-5'-YL-IMIDODIPHOSPHATE-MEDIATED AND OPIATE-MEDIATED INHIBITION OF RAT STRIATAL ADENYLATE-CYCLASE [J].
AHLIJANIAN, MK ;
HALFORD, MK ;
COOPER, DMF .
JOURNAL OF NEUROCHEMISTRY, 1987, 49 (04) :1308-1315
[2]   REGULATION BY DOPAMINERGIC NEUROTRANSMISSION OF DOPAMINE-D2 MESSENGER-RNA AND RECEPTOR LEVELS IN THE STRIATUM AND NUCLEUS-ACCUMBENS OF THE RAT [J].
ANGULO, JA ;
COIRINI, H ;
LEDOUX, M ;
SCHUMACHER, M .
MOLECULAR BRAIN RESEARCH, 1991, 11 (02) :161-166
[3]  
ARNT J, 1984, POL J PHARMACOL PHAR, V36, P221
[4]  
BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675
[5]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[6]   CONTINUOUS TREATMENT WITH THE D(2)-DOPAMINE RECEPTOR AGONIST QUINPIROLE DECREASES D(2)-DOPAMINE RECEPTORS, D(2)-DOPAMINE RECEPTOR MESSENGER-RNA AND PROENKEPHALIN MESSENGER-RNA, AND INCREASES MU-OPIOID RECEPTORS IN MOUSE STRIATUM [J].
CHEN, JF ;
ALOYO, VJ ;
WEISS, B .
NEUROSCIENCE, 1993, 54 (03) :669-680
[7]   NEURONAL LOCALIZATION AND MODULATION OF THE D2 DOPAMINE RECEPTOR MESSENGER-RNA IN BRAIN OF NORMAL MICE AND MICE LESIONED WITH 6-HYDROXYDOPAMINE [J].
CHEN, JF ;
QIN, ZH ;
SZELE, F ;
BAI, G ;
WEISS, B .
NEUROPHARMACOLOGY, 1991, 30 (09) :927-+
[8]   REPEATED TRICYCLICS INDUCE A PROGRESSIVE DOPAMINE AUTORECEPTOR SUBSENSITIVITY INDEPENDENT OF DAILY DRUG-TREATMENT [J].
CHIODO, LA ;
ANTELMAN, SM .
NATURE, 1980, 287 (5781) :451-454
[9]  
CIVELLI O, 1991, UER J PHARM-MOLEC PH, V207, P227
[10]   INCREASE IN STRIATAL DOPAMINE D2-RECEPTOR MESSENGER-RNA AFTER LESIONS OF HALOPERIDOL TREATMENT [J].
COIRINI, H ;
SCHUMACHER, M ;
ANGULO, JA ;
MCEWEN, BS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (2-3) :369-371